Does INEBILIZUMAB Cause Progressive multifocal leukoencephalopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Progressive multifocal leukoencephalopathy have been filed in association with INEBILIZUMAB (UPLIZNA). This represents 7.6% of all adverse event reports for INEBILIZUMAB.
5
Reports of Progressive multifocal leukoencephalopathy with INEBILIZUMAB
7.6%
of all INEBILIZUMAB reports
5
Deaths
5
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From INEBILIZUMAB?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INEBILIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does INEBILIZUMAB Cause?
Off label use (20)
Neuromyelitis optica spectrum disorder (17)
Covid-19 (7)
Pneumocystis jirovecii pneumonia (7)
Pneumonia (6)
Pyrexia (6)
Respiratory failure (5)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)